MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, OPRX had $9,985K increase in cash & cash equivalents over the period. $18,657K in free cash flow.

Cash Flow Overview

Change in Cash
$9,985K
Free Cash flow
$18,657K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Stock-based compensation
    • Net income (loss)
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Repayment of long-term debt
    • Revenue share payable
    • Cash paid for employee withholdi...
    • Others

Cash Flow
2025-12-31
Net income (loss)
5,132
Depreciation and amortization
4,327
Impairment charges
368
Bad debt expense
0
Stock-based compensation
6,962
Amortization of debt issuance costs
1,110
Accounts receivable
-460
Prepaid expenses and other assets
467
Accounts payable
-520
Revenue share payable
-1,967
Accrued expenses and other liabilities
3,374
Operating lease liabilities
12
Taxes receivable and payable
-1,070
Deferred tax liabilities
-1,214
Deferred loan fees
250
Deferred revenue
30
Net cash provided by operating activities
18,715
Purchases of property and equipment
58
Capitalized software development costs
126
Net cash provided by (used in) investing activities
68
Repayment of long-term debt
8,000
Cash paid for employee withholding taxes related to the vesting of restricted stock units
1,150
Proceeds from exercise of stock options, net of cash paid for withholding taxes
352
Net cash used in financing activities
-8,798
Net increase (decrease) in cash and cash equivalents
9,985
Cash and cash equivalents beginning of period
13,380
Cash and cash equivalents end of period
23,365
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Stock-based compensation$6,962K Net income (loss)$5,132K Depreciation andamortization$4,327K Accrued expenses andother liabilities$3,374K Capitalized softwaredevelopment costs$126K Deferred tax liabilities-$1,214K Amortization of debt issuancecosts$1,110K Accounts receivable-$460K Impairment charges$368K Deferred revenue$30K Operating leaseliabilities$12K Net cash provided byoperating activities$18,715K Net cash provided by(used in) investing...$68K Canceled cashflow$4,274K Canceled cashflow$58K Net increase(decrease) in cash and cash...$9,985K Canceled cashflow$8,798K Revenue share payable-$1,967K Taxes receivable andpayable-$1,070K Accounts payable-$520K Prepaid expenses andother assets$467K Deferred loan fees$250K Proceeds from exercise ofstock options, net of...$352K Purchases of property andequipment$58K Net cash used infinancing activities-$8,798K Canceled cashflow$352K Repayment of long-termdebt$8,000K Cash paid foremployee withholding...$1,150K

OptimizeRx Corp (OPRX)

OptimizeRx Corp (OPRX)